EVs, Big Pharma, Tech and the Tariff Threat

EVs, Big Pharma, Tech and the Tariff Threat

Suivant

S&P 500 Closes at Record High in Tech-Led Advance

Watch Bloomberg Businessweek Daily LIVE every day on YouTube: http://bit.ly/3vTiACF.Wall Street traders parsing a batch of economic reports in a session marked by a slowdown in transactions drove stocks to all-time highs. Short-dated bonds underperformed. The dollar fell.In a nar ...  Afficher plus

The Future of Women's Health Begins at MIT

Palmetto is a consumer home energy marketplace aimed at accelerating the transition to a clean energy future. Through a data-driven platform, Palmetto empowers homeowners to understand their energy use, discover personalized savings opportunities, and seamlessly purchase, finance ...  Afficher plus

Épisodes Recommandés

A Nightmare Tariff Scenario for the Auto Industry — ft. Tim Higgins
Prof G Markets

Ed opens the show by discussing Trump’s tariffs, xAI’s purchase of X, and OpenAI’s record-breaking funding round. Then Tim Higgins, Wall Street Journal columnist covering the automobile industry, joins the show to break down how the auto tariffs will impact the car industry and t ...  Afficher plus

Harris Touts Economic Agenda in North Carolina
Balance of Power

 Watch Joe and Kailey LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Washington Correspondents Joe Mathieu and Kailey Leinz deliver insight and analysis on the latest headlines from the White House and Capitol Hill, including conversations with influential lawmakers ...  Afficher plus

The Biggest Indian Pharma Deal of the Decade
The Morning Brief

Mankind Pharma has announced it will buy biotech company BSV for a whopping Rs 13,630 crore. The deal brings together a master of mass market products and an intrinsic innovator in the high entry barrier spaces of the healthcare market. It’s an expensive buy and Mankind has gone ...  Afficher plus

Tesla’s EVs stall in China
FT News Briefing

Enthusiasm about artificial intelligence masks a recession in the technology sector, and a new exchange traded fund looks specifically for ‘reject’ stocks. Plus, Google heads back to court over fresh antitrust allegations, and Chinese car buyers ditch Tesla for local alternati ...

  Afficher plus